Clinical studies recruiting near Taiyuan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · First Hospital of Shanxi Medical University · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-56005, Taiyuan, Shanxi province · Colorado Prevention Center · NCT06024746 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Shanxi Cancer Hospital ( Site 2033) · Merck Sharp & Dohme LLC · NCT06136559 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Shanxi Medical University Second Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Shanxi Bethune Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Phase 1/Phase 2 · First Hospital of Shanxi Medical University · Chipscreen Biosciences, Ltd. · NCT07129382 Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
EARLY_Phase 1 · First Hospital of Shanxi Medical University · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05145361 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
Phase 1 · Shanxi Cancer Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05194982 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · First Hospital of Shangxi Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · First Hospital of Shanxi Medical University · Takeda · NCT06671496 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 1560013 · Sanofi · NCT07190196 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Shanxi Bethune Hospital · Shanghai Henlius Biotech · NCT07160335 The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · Shanxi Provincial People's Hospital · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035 The Chinese Familial Alzheimer's Network
Phase N/A · The First Affiliated Hospital of Shanxi Medical University · Capital Medical University · NCT03657732 Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Phase 2 · Shanxi Provincial Cancer Hospital · Shandong University · NCT06251947 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Phase 2 · Shanxi Cancer Hospital · Tianjin Medical University Cancer Institute and Hospital · NCT07733830 QLS5212 for Participants With Advanced Solid Tumors
Phase 1 · Shanxi Provincial Cancer Hospital (China Medical Sciences Ac · Qilu Pharmaceutical Co., Ltd. · NCT07467629 Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT
NA · Shanxi Bethune Hospital · Shanxi Bethune Hospital · NCT06909071 A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Phase 1 · Shanxi Provincial Cancer Hospital · Suzhou Genhouse Bio Co., Ltd. · NCT06796699 Child-Parent Familial Hypercholesterolemia Screening
Phase N/A · Shanxi Provincial Children's Hospital · Children's Hospital of Fudan University · NCT04529967 The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment S
NA · Shanxi Bethune Hospital · Beijing Chao Yang Hospital · NCT07136025 Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NA · Research Site · AstraZeneca · NCT07516184 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese
Phase 3 · Shanxi Eye Hospital · Hoffmann-La Roche · NCT05562947 Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Phase 4 · China Academy of Chinese Medical Sciences Xiyuan Hospital Sh · Xiyuan Hospital of China Academy of Chinese Medical Sciences · NCT06093932 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Shanxi Bethune Hospital · Turning Point Therapeutics, Inc. · NCT03093116 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · The First Hospital of Shanxi Medical University · Huashan Hospital · NCT05965128 GenSci143 in Participants With Advanced Solid Tumors
Phase 1 · The First Hospital of Shanxi Medical University · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07252414 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Phase 2 · First Hospital of Shanxi Medical University · Zenith Epigenetics · NCT04986423 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Shanxi Bethune Hospital · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297

Look up another city

Look up another condition